LLY vs BDX
By Alex · Tickerpine
Eli Lilly and Company vs Becton, Dickinson and Company, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | BDX |
|---|---|---|
| Price | $1,273.46 | $198.91 |
| Market cap | $1.14T | $54.18B |
| P/E ratio | 42.7 | 46.3 |
| ROE | 102.29% | 6.61% |
| Profit margin | 33.53% | 4.19% |
| Revenue growth | 47.70% | 5.40% |
| Dividend yield | 0.54% | 2.11% |
| Beta | 0.45 | 0.28 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs BDX in plain English
- LLY is the bigger company — about 21.0× the market cap of BDX.
- LLY is cheaper on earnings (P/E 42.7 vs 46.3).
- LLY earns a higher return on equity (102% vs 7%).
- LLY is growing revenue faster (48% vs 5%).
- BDX has the higher dividend yield (2.11% vs 0.54%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
BDX return calculator
See what $1,000 in Becton, Dickinson and Company would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.